⌘K

Home/Filings/4/0000950170-25-109858

4//SEC Filing

Apeiron Investment Group Ltd. 4

Accession 0000950170-25-109858

CIK 0001840904other

View on SEC.gov Company Profile

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 6:00 PM ET

Size

7.0 KB

Accession

0000950170-25-109858

Insider Transaction Report

Form 4

Period: 2025-08-14

ATAI Life Sciences N.V.ATAI

Angermayer Christian

Director10% Owner

Transactions

Purchase
Common Shares
2025-08-14$2.19/sh+8,675,799$19,000,000→ 51,045,214 total(indirect: By Apeiron Investment Group Ltd.)

Holdings

Common Shares
(indirect: By Apeiron Presight Capital Fund II, L.P.)
1,799,302

Apeiron Investment Group Ltd.

10% Owner

Transactions

Purchase
Common Shares
2025-08-14$2.19/sh+8,675,799$19,000,000→ 51,045,214 total(indirect: By Apeiron Investment Group Ltd.)

Holdings

Common Shares
(indirect: By Apeiron Presight Capital Fund II, L.P.)
1,799,302

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

ATAI Life Sciences N.V.

CIK 0001840904

Entity typeother

IncorporatedMalta

Related Parties

1

filerCIK 0001845711

Filing Metadata

Form type: 4
Filed: Aug 17, 8:00 PM ET
Accepted: Aug 18, 6:00 PM ET
Size: 7.0 KB

View on SEC.gov